Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.
CNN1y
Chimerix, Inc.
Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.